Challenges in the Vaccination of the Elderly and Strategies for Improvement
Open Access
- 22 April 2023
- journal article
- review article
- Published by MDPI AG in Pathophysiology
- Vol. 30 (2) , 155-173
Abstract
In recent years, the elderly has become a rapidly growing proportion of the world’s population as life expectancy is extending. Immunosenescence and inflammaging contribute to the increased risk of chronic non-communicable and acute infectious diseases. Frailty is highly prevalent in the elderly and is associated with an impaired immune response, a higher propensity to infection, and a lower response to vaccines. Additionally, the presence of uncontrolled comorbid diseases in the elderly also contributes to sarcopenia and frailty. Vaccine-preventable diseases that threaten the elderly include influenza, pneumococcal infection, herpes zoster, and COVID-19, which contribute to significant disability-adjusted life years lost. Previous studies had shown that conventional vaccines only yielded suboptimal protection that wanes rapidly in a shorter time. This article reviews published papers on several vaccination strategies that were developed for the elderly to solve these problems: more immunogenic vaccine formulations using larger doses of antigen, stronger vaccine adjuvants, recombinant subunit or protein conjugated vaccines, newly developed mRNA vaccines, giving booster shots, and exploring alternative routes of administration. Included also are several publications on senolytic medications under investigation to boost the immune system and vaccine response in the elderly. With all those in regard, the currently recommended vaccines for the elderly are presented.Keywords
This publication has 111 references indexed in Scilit:
- The Impact of Infection on Population Health: Results of the Ontario Burden of Infectious Diseases StudyPLOS ONE, 2012
- Direct Comparison of an Inactivated Subvirion Influenza A Virus Subtype H5N1 Vaccine Administered by the Intradermal and Intramuscular RoutesThe Journal of Infectious Diseases, 2012
- Vaccination‐induced changes in human B‐cell repertoire and pneumococcal IgM and IgA antibody at different agesAging Cell, 2011
- MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza VaccinesScience Translational Medicine, 2011
- The Biology of Aging and FrailtyClinics in Geriatric Medicine, 2011
- Pneumococcal vaccination in older adults induces antibodies with low opsonic capacity and reduced antibody potencyVaccine, 2008
- Intradermal Influenza Vaccine Administered Using a New Microinjection System Produces Superior Immunogenicity in Elderly Adults: A Randomized Controlled TrialThe Journal of Infectious Diseases, 2008
- Biology of Immune Responses to Vaccines in Elderly PersonsClinical Infectious Diseases, 2008
- Immunosenescence: emerging challenges for an ageing populationImmunology, 2007
- A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older AdultsNew England Journal of Medicine, 2005